This trial will test whether Lutathera is effective in treating meningioma. Lutathera will be given intravenously every 8 weeks for 4 doses, and PET-MRI scans will be done before treatment and 6 months after the start of treatment.
1 Primary · 4 Secondary · Reporting Duration: 2 Years Post Treatment
Experimental Treatment
32 Total Participants · 1 Treatment Group
Primary Treatment: Lutathera · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: